Not Yet RecruitingNot Applicable

Autonomic Dysfunction in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis : A Comparative Study

100 participantsStarted 2026-01-20

Plain-language summary

To compare the frequency and patterns of autonomic dysfunction in patients with NMOSD and MS, and to investigate its correlations with clinical disability, radiological findings, fatigue, and quality of life parameters

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients (≥18 years , both sexes. * Confirmed diagnosis of NMOSD according to the 2015 International Consensus Criteria. * Confirmed diagnosis of RRMS according to the 2024 McDonald diagnostic criteria. Exclusion Criteria: * Comorbidities affecting autonomic function (e.g., diabetes, Parkinsonism). * Medications known to interfere with autonomic testing. * Cognitive impairment precluding questionnaire completion.

What they're measuring

Prevalence of autonomic dysfunction in Neuromyelitis Optica Spectrum Disorder

Timeframe: Baseline

Trial details

NCT IDNCT07273292

SponsorMohamed Moshref abd alsattar

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-09

Contact for this trial

Mohamed Moshref Abd alsattar, Master

0201068960922 mohamedmshrf47@gmail.com

View on ClinicalTrials.gov More NMO and MS trials